• What Is The Future Of Using Outcomes-Based Contracts Between Payers And Pharmaceutical Manufacturers To Gain Market Access For Advanced Oncologic And Biologic Agents?

    May 1, 2018, 00:00
  • Association of Appropriate Pharmacotherapy Management of Copd Exacerbation and Risk of Subsequent Readmission

    May 1, 2018, 00:00
  • Healthcare Resource Use (HRU) Associated with Severe Adverse Events (AES) Of Interest in Adults With Relapsed or Refractory (R/R) B-Precursor Acute Lymphoblastic Leukemia (All) In Eu-4 Countries

    May 1, 2018, 00:00
  • Value-Based Care In Oncology- Challenges And Barriers Amongst Community Oncologists

    May 1, 2018, 00:00
  • Trastuzumab Uptake In HER2-Positive Breast Cancer Patients- A Systematic Review And Meta-Analysis Of Observational Studies

    May 1, 2018, 00:00
  • A Cost-Utility Analysis of Atovaquone-Proguanil vs. Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria in the United States

    May 1, 2018, 00:00
  • The Comparative Efficacy, Safety, And Reactogenicity, of Herpes Zoster Vaccines- A Network Meta-Analysis

    May 1, 2018, 00:00
  • Biosimilar Market Access – Comparing the US and European Markets

    May 1, 2018, 00:00
  • Age and Racial Disparities in Human Pappilomavirus (HPV) Vaccination Series Completion in Mississippi Medicaid

    May 1, 2018, 00:00
  • Accessing Medications in the United States- A Systemic Review of the Challenges and Barriers

    May 1, 2018, 00:00
  • Emphasizing Quality of Life in Treatment Recommendations for Node-Positive Stage III Non-Small Cell Lung Cancer

    May 1, 2018, 00:00
  • The Influencing of Hospitalization Costs Through Length of Stay Among Inpatients with Positive Antimicrobial Susceptibility Based on the Method of Structural Equation Model

    May 1, 2018, 00:00
  • The Reporting Quality of Pharmacoeconomic Studies Before and After Publication of the Cheers Checklist

    May 1, 2018, 00:00
  • Evaluation Of The Disease-Specific Items On The Eortc In Hepatocellular Carcinoma Patients Treated With Lenvatinib Or Sorafenib

    May 1, 2018, 00:00
  • Healthcare Cost Associated with Cardiac Implantable Electronic Device Infections- Using a National Health Insurance Claims Database

    May 1, 2018, 00:00
  • Cost Effectiveness Analysis of Intra-Articular Triamcinolone Acetonide Extended-Release Injectable Suspension (TA-ER) Versus Triamcinolone Acetonide Crystalline Suspension For Symptomatic Knee Osteoarthritis

    May 1, 2018, 00:00
  • A Foot In The Door Or One Foot In The Grave? The Role Of Real World Evidence In Cancer Drugs Fund Re-Appraisals

    May 1, 2018, 00:00
  • A Real-World Data Analysis Evaluating the Time to Glycemic Control After Initiation of Basal Insulin in Type 2 Diabetic Patients

    May 1, 2018, 00:00
  • Impact of European Medicines Agency (EMA) Clinical Trial Transparency Policies on Health Technology Assessment (HTA) Decisions In the UK

    May 1, 2018, 00:00
  • Age-Related Hospital Utilization Among Patients with Marfan Syndrome

    May 1, 2018, 00:00
  • Variation in Physician’s Recommendation of Blood Pressure Self-Monitoring in the United States- Results from Nhanes 2009 – 2014

    May 1, 2018, 00:00
  • The Cost of New Oral Anti-Diabetic Drugs in Canada and Internationally

    May 1, 2018, 00:00
  • Health Insurance Cost Related to the Additional Treatment and Complications of Patients Involved into Clinical Trials

    May 1, 2018, 00:00
  • Cost-Effectiveness of Cetuximab for Left-Side Metastatic Colorectal Cancer in Ecuador

    May 1, 2018, 00:00
  • Financial Burden Over Time in Older Adults with Cancer, Heart Disease, or Diabetes

    May 1, 2018, 00:00
  • Impact of Affordable Care Act on Medicare Disproportionate Share Hospital (DSH) Payments

    May 1, 2018, 00:00
  • Out-of-Pocket Cost Burden and Price Elasticity of Demand for Ivacaftor use in Cystic Fibrosis

    May 1, 2018, 00:00
  • Association Between Exenatide/Β2AR Use and Parkinson’s Disease Risk in Medicare Population

    May 1, 2018, 00:00
  • Treatment Patterns PSA

    May 1, 2018, 00:00
  • The Influence on Coping Style in Patients with Schizophrenia By Naikan Therapy

    May 1, 2018, 00:00
  • Cost Effectiveness Analysis of Risperidone and Olanzapine in Schizophrenic Patients

    May 1, 2018, 00:00
  • Hepatitis C Patient Characteristics Across Antiviral Treatment Eras in a Large Managed Care Organization

    May 1, 2018, 00:00
  • An Analysis of Outpatient Healthcare Utilization and Costs in Children with Severe Mucopolysaccharidosis Type I in the United States

    May 1, 2018, 00:00
  • Treatment Utilization Patterns Among Elderly Patients Diagnosed With Follicular Lymphoma In The United States Between 2000 And 2013

    May 1, 2018, 00:00
  • Epidemiology Of Hyperhidrosis in the United States- A Systematic Literature Review

    May 1, 2018, 00:00
  • An Open-Source Toolkit for Developing Flexible Evidence-Based Decision and Simulation Models for Value Assessment in Oncology with R

    May 1, 2018, 00:00
  • Retrospective Validation of Predicted Long-Term Survival Estimates from an Early Data Cut of the Phase III Checkmate 025 Study in Advanced Renal Cell Carcinoma

    May 1, 2018, 00:00
  • Clinical and Economic Impact of Switching from Negative- or Neutral Displacement Needleless Connectors to Positive Displacement Needleless Connectors in Central Vascular Access Settings

    May 1, 2018, 00:00
  • Shift in the Status Quo- How Biosimilar Interchangeability Can Lead to Significant Cost Savings

    May 1, 2018, 00:00
  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Peripheral T-Cell Lymphoma (PTCL)- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00
  • The Frequency and Availability of Population-Specific Patient Reported Outcome Measures and Minimal Clinically Important Differences Among Approved Drugs in Canada

    May 1, 2018, 00:00
  • ICERS are Not All the Same. How Cost-Effectiveness Estimates Differ Between the UK and US

    May 1, 2018, 00:00
  • Trends of Antibiotic Consumption in Intensive Care Units of Colombia, 2010-2016

    May 1, 2018, 00:00
  • Health Technology and Regulatory Assessment of Adherence and Improved Outcomes for Second Generation Antipsychotics in Schizophrenia

    May 1, 2018, 00:00
  • Pharmacoeconomic Assessment of Biological Therapy of Ulcerative Colitis

    May 1, 2018, 00:00
  • Potential Risks and Benefits for Using Nsaids in The Treatment of Rheumatoid Arthritis

    May 1, 2018, 00:00
  • Budget Impact Analysis of Oritavancin for the Treatment of Moderate to Severe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) from a Hospital Perspective

    May 1, 2018, 00:00
  • Budget Impact Analysis (BIA) of Point-of-Care of HBA1C Monitoring in Belgian, German and Swiss Patients with Diabetes Mellitus Type II

    May 1, 2018, 00:00
  • Choice Defines Qalys- A US Valuation of the EQ-5D-5L

    May 1, 2018, 00:00
  • Comparison Of Bleeding Events, Strokes, And Myocardial Infarcts On Warfarin Or Dabigatran For Treatment Of Atrial Fibrillation- Results Of A Real-World Data Analysis

    May 1, 2018, 00:00
  • Association of Disease Modifying Antirheumatic Drugs (DMARD) and Tumor Necrosis Factor (TNF)- Alpha Inhibitor Therapy and Infection In Rheumatoid Arthritis Patients in a Medicaid Population

    May 1, 2018, 00:00
  • Cost-Minimization Analysis of Biological Drugs in the Treatment of Ankylosing Spondylitis from a Brazilian Perspective

    May 1, 2018, 00:00
  • Evaluation of Subcutaneous Rituximab Administration Impacts on Canadian Systemic Therapy Suites

    May 1, 2018, 00:00
  • Risk-Sharing Agreement- A Model For Her2 (+) Breast Cancer Suitable For The Chilean Context

    May 1, 2018, 00:00
  • Availability of Real-World Evidence (RWE) to Support Economic Modelling in Primary Progressive Multiple Sclerosis (PPMS)

    May 1, 2018, 00:00
  • Examining Job Satisfaction, Stress, Flexibility, And Career Success Factors in the Health Economics, Outcomes Research, And Market Access (HEORMA) Profession Based on a Global Cross-Sectional Study

    May 1, 2018, 00:00
  • Predictors of All-Cause Healthcare Payments Among Patients With Treatment-Resistant Major Depressive Disorder

    May 1, 2018, 00:00
  • Clotting Factor (CF) Product Administration And Risk Of Thrombotic Adverse Events (TES) Among The Inpatient U.S. Elderly Medicare Beneficiaries, During 2009-2015 Study Period

    May 1, 2018, 00:00
  • Rate and Reimbursement of Ankle Screw Removal Procedures after Syndesmotic Fixation

    May 1, 2018, 00:00
  • Cost-Effectiveness of Tacrolimus for the Treatment of Moderate-to-Severe Lupus Nephritis

    May 1, 2018, 00:00
  • Cost-Effectiveness Evaluation of Ertapenem in the Treatment of Adult Patients with Community-Acquired Complicated Urinary Tract Infections

    May 1, 2018, 00:00
  • Cost Estimates of Human Immunodeficiency Virus (HIV) Disease Management in the United States - A Literature Review

    May 1, 2018, 00:00
  • Utilization of a Precise, Clinically Relevant, Digital Classification System to Identify Variation in Care and Costs Among Patients with Breast Cancer

    May 1, 2018, 00:00
  • Effect of Vitamin D Supplementation on HIV Outcomes- A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    May 1, 2018, 00:00
  • Surgical Procedures for Knee Osteoarthritis- Volume and Costs Among the Commercially-Insured Patients in the United States

    May 1, 2018, 00:00
  • Predictive Modelling for Secondary Prevention of Alzheimer’s Disease- Ethical Concerns and Social Implications Based on Targeted, Narrative Literature Review

    May 1, 2018, 00:00
  • Economic Evaluation of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) for Immune Tolerance Induction (ITI) in Patients with Hemophilia a WHO Develop Inhibitors Under the Brazilian Unified Health System (SUS) Perspective

    May 1, 2018, 00:00
  • FLT3 Mutated and Wildtype Acute Myeloid Leukemia Treatment Patterns and Outcomes at a Comprehensive Cancer Center

    May 1, 2018, 00:00
  • New Structured Search Method that Allows Identify and Map Potential Patients with Cystic Fibrosis Not Yet Diagnosed

    May 1, 2018, 00:00
  • Biosimilar Regulatory Policies Issues and Implications- Where are we Headed?

    May 1, 2018, 00:00
  • Clinical, Humanistic, and Economic Burden of Osteoarthritis (OA) Among Noninstitutionalized Adults in the United States (US)

    May 1, 2018, 00:00
  • A Systematic Review of Population-Based Studies on Pain Self-Management Strategies and Outcomes

    May 1, 2018, 00:00
  • Assessment of the Burden of Multiple Sclerosis On Family Caregivers By Patient Disability Severity

    May 1, 2018, 00:00
  • Development of Patient-Reported Outcome Measures for Masseter Prominence

    May 1, 2018, 00:00
  • Feminine Hygiene Product Use and Awareness Among Young Us Adults

    May 1, 2018, 00:00
  • Diabetes Mellitus and Suicide Risk in Males and Females- A Literature Review

    May 1, 2018, 00:00
  • Trends in Approval of Therapeutic Biologic Approved by the US Food and Drug Administration (1986–2017)

    May 1, 2018, 00:00
  • Cost-Effectiveness of a Twin Interlocking Derotation and Compression Screw Cephalomedullary Nail (2-Screw Nail)* with a Single Screw Derotation Cephalomedullary Nail (Single-Screw Nail)** in Patients with Intertrochanteric HIP Fractures

    May 1, 2018, 00:00
  • Armed Conflict and Infant Mortality Due to Diarrhea in Colombian Children

    May 1, 2018, 00:00
  • Clinical Outcome Assessments- Use of Normative Data in a Pediatric Rare Disease

    May 1, 2018, 00:00
  • Consumer Preferences for Precision Medicine Technologies- Evidence from A Discrete Choice Experiment

    May 1, 2018, 00:00
  • Development and Validation of a Model to Predict Cessation of Antihyperglycemic Medication after Laparoscopic Bariatric Surgery Among Patients with Type 2 Diabetes

    May 1, 2018, 00:00
  • Cost-of-Illness and Treatment Patterns of Gynecologic Cancer in the United States- An Empirical Analysis Based On MEPS Database 2007-2014

    May 1, 2018, 00:00
  • Cervical Cancer Screening Decision Model

    May 1, 2018, 00:00
  • Ultrafiltration vs. Diuretics for the treatment of Fluid Overload in Heart Failure Patients- A Hospital Cost Analysis

    May 1, 2018, 00:00
  • Budget Impact of the Introduction of Subcutaneous Rituximab to U.S. Health Plans

    May 1, 2018, 00:00
  • A 2-Arm Randomized Pilot Study To Evaluate The Impact Of A Mobile Health Application On Medication Adherence In Patients On Oral Anti-Cancer Medications

    May 1, 2018, 00:00
  • Ultrasound- A Fast Low-Cost Tool for the Diagnosis of Rheumatoid Arthritis in a Specialized Center

    May 1, 2018, 00:00
  • Consumption of Biologic Treatments for Rheumatoid Arthritis in the Brazilian Public Health System

    May 1, 2018, 00:00
  • How Patient Organizations are Using Patient-Reported Outcomes- Survey Results from a Non-Probability Sample of Patients Count Network Members

    May 1, 2018, 00:00
  • Longitudinal Analysis Of Adjusted EQ-5D Utility Score At Baseline, Progression-Free Survival, And Progression For Lenvatinib Versus Sorafenib

    May 1, 2018, 00:00
  • Evaluation of the Cost Per Patient Achieving Composite and Single Treatment Targets with Once-Weekly Semaglutide and Exenatide ER in the United States

    May 1, 2018, 00:00
  • Reimbursement of Medicines in Ukraine- Issues and Challenges

    May 1, 2018, 00:00
  • Cost-Effectiveness of Cognitive Behavioral Therapy Delivered Via Internet for Children with Functional Abdominal Pain Disorders- Evaluation Alongside A Randomized Controlled Trial

    May 1, 2018, 00:00
  • Trends in the Economic Value of Newly Approved Cancer Therapies in the U.S

    May 1, 2018, 00:00
  • Assessing Symptom Change at the Individual Level Using Item Response Theory Versus Sum Scoring- Implications for Depression Treatment

    May 1, 2018, 00:00
  • Effect of Core Stability Training Program Among Ice Hockey Players

    May 1, 2018, 00:00
  • Benefits of a Heart-Shaped Suturing Technique in Cesarotomy Closure- Experience from an Academic Medical Center in China

    May 1, 2018, 00:00
  • Oncology Combination Pricing- Impact of Product Characteristics and Unmet Need

    May 1, 2018, 00:00
  • Predictors of Annual Salary for Health Economics, Outcomes Research, and Market Access Professionals

    May 1, 2018, 00:00
  • A Prediction Model for Length of Stay in the Icu Among Septic Patients- A Machine Learning Approach

    May 1, 2018, 00:00
  • Effects of Canagliflozin on Cardiovascular Outcomes and All Cause Mortality- A Review And Meta-Analysis

    May 1, 2018, 00:00
  • Secondary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines- A Retrospective Cohort Analysis

    May 1, 2018, 00:00
  • Budget Impact of a Fixed-Dose Combination Therapy of Lesinurad and Allopurinol for Second-Line Gout Therapy- A US Commercial Health Plan Perspective

    May 1, 2018, 00:00
  • Adherence to Antiretrovirals in Medicaid-Insured Patients Living with HIV- Predictors and Economic Consequences

    May 1, 2018, 00:00
  • Cost Effectiveness of Ultra-Violet Germicidal Irradiation in Canadian Health Region

    May 1, 2018, 00:00
  • Treatment Patterns Of Alk+ Non-Small Cell Lung Cancer Patients In The United States And Western Europe

    May 1, 2018, 00:00
  • EQ-5D-3L Decrements By Diabetes Complications and Comorbidities in China

    May 1, 2018, 00:00
  • Harnessing Big Data- A Methodological Approach to Linking Electronic Health Records with Patient-Reported Survey Data

    May 1, 2018, 00:00
  • Colorectal Cancer Screening Pilot Program Results In Hungary

    May 1, 2018, 00:00
  • Healthcare Resource Utilization and Direct Medical Costs Among Adult Patients with Chronic Hepatitis C in China

    May 1, 2018, 00:00
  • Systematic Review of Patient Perspectives and Quality of Life Outcomes Associated with Use of Topical Interventions for Treatment of Chronic Wounds

    May 1, 2018, 00:00
  • Burden of Hospitalization In Lung Cancer Patients with Brain Metastases- Analysis Of US National in-Patient Data for 2015 Using ICD-9 and ICD-10 Diagnoses

    May 1, 2018, 00:00
  • A Method to Use Administrative Claims to Categorize Dementia Cases by Subtype

    May 1, 2018, 00:00
  • Improved Quality Control With Subcutaneous (SC) Infusion Pump

    May 1, 2018, 00:00
  • Characterizing Patients Treated With Macitentan For Pulmonary Arterial Hypertension (PAH) In The U.S. Opsumit Users Registry (OPUS)

    May 1, 2018, 00:00
  • Patterns Of Health Service Utilization Among Patients Undergoing Hematopoietic Cell Transplantation — A Person-Centered Approach

    May 1, 2018, 00:00
  • Linkage Between Orthopedic Registry and Administrative Data Using Indirect Identifiers for National Device Infrastructure Development

    May 1, 2018, 00:00
  • Using Real World Data to Establish An Optimal Treatment Target for HBA1C in Diabetes Type 2

    May 1, 2018, 00:00
  • Comparison of Healthcare Resource Utilization (HRU) and Costs Related to Pleural Effusion (PE) Between Patients Newly Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Dasatinib or Nilotinib as First-Line Therapy in the United Stat ...

    May 1, 2018, 00:00
  • Estimating the Cost and Cost-Effectiveness for Obstetric Fistula Repair in Low-Income Countries

    May 1, 2018, 00:00
  • Once Daily Vibegron Improves Quality of Life Measures in Patients with Overactive Bladder

    May 1, 2018, 00:00
  • The Problem of Rarity- Estimation of Prevalence in Rare Disease

    May 1, 2018, 00:00
  • Health Utility of Hospitalized Stroke Patients in Vietnam, Comparing Early Stage to Discharge

    May 1, 2018, 00:00
  • The Economic Burden of Erectile Dysfunction and Related Comorbidities- A Medicare Perspective

    May 1, 2018, 00:00
  • The Impact of Online Patient Communities on Patient Outcomes- A Systematic Review

    May 1, 2018, 00:00
  • Evaluation of Electronic Health Record Data Quality to Assess the Clinical Indices of Anemia in Dialysis Patients

    May 1, 2018, 00:00
  • Health Techonolgy Assessment (HTA) Agencies Consideration of Real World Evidence (RWE)

    May 1, 2018, 00:00
  • Health Technology Assessment of Gene Therapies for Inherited Genetic Disorders in the US and Europe

    May 1, 2018, 00:00
  • Assessment of Anticholinergic Burden scales and Measures for Estimating Anticholinergic Exposure in Retrospective u.s. Database Analyses

    May 1, 2018, 00:00
  • Utilization Patterns Of The First US Biosimilar, Filgrastim-Sndz, Observed Between 2015 And 2017 In A Medical Transcription Database

    May 1, 2018, 00:00
  • Clinical Core Outcomes Sets in Real World Data

    May 1, 2018, 00:00
  • The Association Between Airflow Limitation and Early Retirement Using the Health Retirement Survey Data

    May 1, 2018, 00:00
  • What’s the Burden of Burden of Illness Reviews?

    May 1, 2018, 00:00
  • FDA Orphan Exploitation? Are Pharma’s Approaches to Orphan Oncology Drug Approval Fuelling a Push for Reform By the FDA?

    May 1, 2018, 00:00
  • Quantitative Assay of Fecal Calprotectin in Children with Cow’s Milk Protein Allergy

    May 1, 2018, 00:00
  • Impact of the Affordable Care Act (ACA)’S Elimination of Cost-Sharing Provision on the Guideline-Recommended Cancer Preventive Screenings in the United States

    May 1, 2018, 00:00
  • Dose-Response Association Between Concurrent Opioid and Benzodiazepine use and Risk of Opioid- Related Overdose

    May 1, 2018, 00:00
  • Costs Related to Infusion Therapy Room and Staff for Rheumatoid Arthritis in a Specialized Center

    May 1, 2018, 00:00
  • Nasal Glucagon Saves Professional Emergency Medical (EM) Costs Versus Intramuscular Glucagon —A Us Based Cost-Offset Model

    May 1, 2018, 00:00
  • Cost-Effectiveness of Breast Cancer Screening Program in the Republic of Kazakhstan

    May 1, 2018, 00:00
  • Modeling the Reduction in the Clinical Burden of Migraine with Erenumab Treatment

    May 1, 2018, 00:00
  • Emergent Therapies And Egfr Mutation Testing In Non-Small Cell Lung Cancer- Real-World Practices

    May 1, 2018, 00:00
  • Assessing Multi-Criteria Decision Analysis (MCDA) Attribute Weights Using an Interactive Data Capture Tool

    May 1, 2018, 00:00
  • Respiratory Illness (RI) and Respiratory Syncytial Virus (RSV)-Related Hospitalization (RSVH) in Infants with Congenital Diaphragmatic Hernia (CDH) in the Caress Registry (2005-2017)

    May 1, 2018, 00:00
  • Inotersen Improves Quality of Life and Neuropathy in Patients with Hereditary Transthyretin (HATTR) Amyloidosis with Polyneuropathy- Results of the Phase 3 Study Neuro-TTR

    May 1, 2018, 00:00
  • Evaluation On Use Of Digital Refill Reminders On Patient Adherence To Antiretroviral Medications

    May 1, 2018, 00:00
  • Bayesian Network Meta-Analysis of Treatments in Iron Deficiency Anaemia (IDA)

    May 1, 2018, 00:00
  • A Qualitative Study to Explore the Content Validity of Patient-Reported Outcome Measures in a Systemic Lupus Erythematosus Population

    May 1, 2018, 00:00
  • A Systematic Review of Clinical Efficacy Associated with use of Protease-Modulating Interventions with Diabetic Foot Ulcer or Venous Leg Ulcer

    May 1, 2018, 00:00
  • Budget Impact Model of Low Chloride Balanced Intravenous Solutions in Patients with Systemic Inflammatory Response Syndrome from a Hospital Perspective in Colombia

    May 1, 2018, 00:00
  • A Cross Sectional Study of the Factors that Affect Therapy Adherence in Children with Attention Deficit Disorder/ Attention Deficit/Hyperactivity Disorder

    May 1, 2018, 00:00
  • Challenges in Research and Health Technology Assessment of Rare Disease Technologies- Report of the ISPOR Rare Disease Special Interest Group

    May 1, 2018, 00:00
  • Profiles Of Non-Small Cell Lung Cancer Patients Treated With Immuno-Oncology Therapies In The United States And Western Europe

    May 1, 2018, 00:00
  • An Economic Evaluation of Conservative Management and Cryotherapy in Patients with Localized Prostate Cancer

    May 1, 2018, 00:00
  • Development and Preliminary Assessment of the Environment-Based Quality Of Life (EBQOL) Instrument

    May 1, 2018, 00:00
  • Pharmaceutical Expenditures, out of Pocket Costs, and Impact of Provider Factors- Intersection of Health Economics and the Marketing Mix

    May 1, 2018, 00:00
  • Emergency Department (ED) Utilization for Dental Or Oral Health Related Conditions (DOHRC) Before and after Implementation of Affordable Care Act (ACA)

    May 1, 2018, 00:00
  • Management of Biosimilars- Key Considerations for Pharmacists in Patient Care

    May 1, 2018, 00:00
  • Budget Impact Analysis of Implementing 5mm Dual-Ended Safety Pen Needles for Insulin Injections in US Hospitals

    May 1, 2018, 00:00
  • Evaluating Different Indirect Treatment Comparison Approaches- A Case Study in Acute Myeloid Leukemia Patients Ineligible to Receive Intensive Chemotherapy

    May 1, 2018, 00:00
  • Evaluating and Valuing Drugs for Rare Conditions- No Easy Answers

    May 1, 2018, 00:00
  • A Tale of Two Universal Health Insurance Schemes in One Country- Horizontal Inequality of Government Medical and Pharmaceutical Benefits for Australian Children

    May 1, 2018, 00:00
  • Comparative Effectiveness of Second-Line Anti-Diabetic Agents in Delaying Treatment Intensification

    May 1, 2018, 00:00
  • Effect of a Provider-Focused Asthma Care Quality Improvement Program on Patient-Level Asthma-Related Health Care Costs

    May 1, 2018, 00:00
  • Real-World Comparison of Healthcare Costs Among Patients with Type 2 Diabetes Treated with Dulaglutide Vs. Liraglutide in the United States

    May 1, 2018, 00:00
  • Trends in Prescription Opioid Use Among Hemodialysis Patients in the United States, 2007-2014

    May 1, 2018, 00:00
  • A Systematic Review of Health Economic Evaluations in Mexico

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Regorafenib and Tas-102 In Refractory Metastatic Colorectal Cancer

    May 1, 2018, 00:00
  • A Cost-Effectiveness Analysis of Commonly Used Biologic Drugs for the Treatment of Moderate-To-Severe Psoriasis in the United States

    May 1, 2018, 00:00
  • Systematic Review of Diagnosis and Treatment of Obesity and Bing- Eating Syndrome

    May 1, 2018, 00:00
  • Budget Impact Analysis of Basaglar for the Treatment of Type 1 and Type 2 Diabetes in Patients Eligible for a Long-Acting Insulin Analog

    May 1, 2018, 00:00
  • Utilization Evaluation of Antibiotics at Critical Care Setting of a Tertiary Care Hospital

    May 1, 2018, 00:00
  • Do Us Payers Consider Cost-Effectiveness when Defining Prescription Benefits? A Study of Targeted Therapies for Rheumatoid Arthritis and Moderate-To-Severe Psoriasis

    May 1, 2018, 00:00
  • The Effect of Generic Statin Availability on Initial Statin Prescribing Trends Among Medicare Beneficiaries

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Regorafenib for Third-Line Metastatic Colorectal Cancer (MCRC) Compared to Cetuximab Plus Irinotecan in China

    May 1, 2018, 00:00
  • Vascular Access-Specific HRQOL Impacts Among Hemodialysis Patients- The Hemodialysis Access-Related QOL (HARQ) Project Focus Group Results

    May 1, 2018, 00:00
  • Real World Data Analysis of US Claims Database on Coagulation Factor IX Expenditures in Patients with Hemophilia B- Standard half-Life Vs. Extended Half-Life Products

    May 1, 2018, 00:00
  • The Efficacy and Safety of Mirabegron Relative to Onabotulinumtoxina in Patients with Overactive Bladder Not Appropriately Managed with An Antimuscarinic- A Network Meta-Analysis

    May 1, 2018, 00:00
  • A Modified Parametric Approach to Model Long-Term Survival of Potentially Curative Therapies- Implications for the Cost-Effectiveness of Car-T Therapies

    May 1, 2018, 00:00
  • Cost of Care for Patients with Metastatic Castration-Resistant Prostate Cancer in US Commercially Insured and Medicare Supplement Plans

    May 1, 2018, 00:00
  • Relationship Between Patient Characteristics and Length of Stay for Severe Burn Patients- Analysis of the American Burn Association National Burn Repository

    May 1, 2018, 00:00
  • Tumor Necrosis Factor Inhibitor Therapy and The Risk of Developing Depression Among Working-Age Adults with Rheumatoid Arthritis

    May 1, 2018, 00:00
  • Missed Opportunities for Influenza and Pneumococcal Vaccinations in the Elderly in the US - A Cross-Sectional Analysis

    May 1, 2018, 00:00
  • Cost-Effectiveness of Niraparib and Olaparib as Maintenance Therapy for Patients with Platinum Sensitive Recurrent Ovarian Cancer

    May 1, 2018, 00:00
  • Assessing Type and Impact of Biases Potentially Occurring when Analyzing Real World Eviden The Case of Second Line Treatment for Ovarian Cancer

    May 1, 2018, 00:00
  • A Comparison Of Patient Level Data (IPD) Regression Techniques In Adjusting For Cross Trial Differences In An Indirect Treatment Comparison (ITC)- A Worked Example Of Simulated Treatment Comparison (STC) Vs Bayesian Ipd Regression

    May 1, 2018, 00:00
  • Cost Treatment Comparison of Abiraterone Acetate Plus Prednisone in the Pre-Chemotherapy Setting Followed by Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration-Resistant Prostate Ca ...

    May 1, 2018, 00:00
  • Overall Treatment Satisfaction with Schizophrenia Therapies- Analysis from Patient, Physician and Caregiver Perspectives

    May 1, 2018, 00:00
  • Economic Value Tool Evaluating Total Procedural Costs Associated with the Creation of Colorectal Anastomoses

    May 1, 2018, 00:00
  • Editorial Board

    May 1, 2018, 00:00
  • Influence Of Critical Disease Insurance (CDI) Policy On Pemetrexed Adherence Among The First-Line Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Patients In Zhejiang Province Of China

    May 1, 2018, 00:00
  • Cost-Effectiveness of Sequential Treatment Strategies with Tnf-Inhibitors in Patients with Ankylosing Spondylitis- A Patient-Level Simulation Model

    May 1, 2018, 00:00
  • Differences in the Flexibility of Muscles of Athletes Doing Weight Training and Functional Training

    May 1, 2018, 00:00
  • Relative Clinical and Economic Burden of Community Acquired Pneumonia in the Elderly

    May 1, 2018, 00:00
  • Financial Impact and Experience with General Medical Services Among Cancer Survivors in the United States

    May 1, 2018, 00:00
  • Updated New Drugs Approval Timing in Italy (2015-2017)

    May 1, 2018, 00:00
  • A Systematic Literature Review of Methodology to Determine Treatment Persistence in Inflammation and Immunology Observational Database Studies

    May 1, 2018, 00:00
  • Real World Incidence and Prevalence of Low Back Pain- A Systematic Review

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Daratumumab, Lenalidomide, and Dexamethasone (DRD) and Daratumumab, Bortezomib, And Dexamethasone (DVD) Versus Standard of Care in Relapsed or Refractory Multiple Myeloma (RRMM)

    May 1, 2018, 00:00
  • Economic Evaluation of Enterex® IMX, A Specialized Nutrition Supplement Containing Arginine, in the Treatment of Neurocritical Patients in México

    May 1, 2018, 00:00
  • Non-Inferiority Clinical Trial Design, Drug Approval, and Implications For Clinicians in Prescribing Oral Anticoagulants

    May 1, 2018, 00:00
  • New Oral Anticoagulants And The Risk Of Vasculitis- A Nested Case-Control Study

    May 1, 2018, 00:00
  • Pharmacoeconomics in Nepal- Need For A Paradigm Shift

    May 1, 2018, 00:00
  • Measuring the Extent and Impact of Disease Sub-Specialization Among Neurologists in the US

    May 1, 2018, 00:00
  • Adverse Drug Reactions (ADRS) Associated with Medications used to Treat HIV/AIDS- 2001-Present

    May 1, 2018, 00:00
  • Evaluation of Current And Future PD-(L)1 Testing Requirements in the US

    May 1, 2018, 00:00
  • Challenges in Valuing Temporary Health States for Economic Evaluation- A Review of Empirical Applications of the Chained Time Trade-Off Method

    May 1, 2018, 00:00
  • Growth of Hospital-Owned Specialty Pharmacies- Importance and Implications for Manufacturer Channel and Patient Access Strategies

    May 1, 2018, 00:00
  • Latest Insights on the Cost Efficiency of Therapeutic Plasma Exchange in Treating Guillain-Barre Syndrome

    May 1, 2018, 00:00
  • Market Access for Advanced Therapy Medicinal Products (ATMPS) Begins at the Bench

    May 1, 2018, 00:00
  • The Impact of Patient-Centered Medical Home on Hypertension-Associated Health Care Utilization and Cost

    May 1, 2018, 00:00
  • Budget Impact Analysis of the Advance Lubricath® Foley Catheter Tray® for Urinary Catheterization of Long Duration in Mexico

    May 1, 2018, 00:00
  • Inclusion of Drugs in a Formulary- A Case Study

    May 1, 2018, 00:00
  • Squaring the Circle? Using Real World Data from Early Access Programs to Inform Pricing and Reimbursement Decision Making

    May 1, 2018, 00:00
  • Factors Predicting Restrictions on US Commercial Payer Coverage of Specialty Drugs

    May 1, 2018, 00:00
  • Predictive Model Directed Interventions Improve Medication Adherence Program Efficiency

    May 1, 2018, 00:00
  • Risk of Diabetes Among Intensive and Moderate Dose Statin Users with Potential Modifying Effects of Treatment Duration

    May 1, 2018, 00:00
  • Infant Mortality from Acute Respiratory Infections and Armed Conflict- An Exploratory Analysis

    May 1, 2018, 00:00
  • Globalization Module for A Diabetes Progression Prediction Model- The Building, Relating, Acting, and Validating Outcomes (Bravo) Model

    May 1, 2018, 00:00
  • Perceived Cancer Risk and Evaluation of Public Awareness of Direct-to-Consumer Genetic Tests in the United States

    May 1, 2018, 00:00
  • Market Access Challenges and Opportunities for Anti-Infectives- An EU5 Perspective

    May 1, 2018, 00:00
  • Patient Characteristics And Treatment Patterns From Spear-Bladder- Study Informing Treatment Pathway Decision In Bladder Cancer

    May 1, 2018, 00:00
  • Cost-Effectiveness of Transcathether Aortic Valve Implantation with the New Repositionable Self-Expandable Evolut R Versus Corevalve System in Inoperable Patients with Severe Aortic Stenosis in Mexico

    May 1, 2018, 00:00
  • Cost-Effectiveness and Return on Investment of Continuous Lateral Rotation Therapy to Prevent Ventilator-Associated Pneumonia and Pressure Injuries in the Critical Care Setting

    May 1, 2018, 00:00
  • Evaluating A Conceptual Platform for Facilitating and Scaling Pharmaceutical Risk Sharing Arrangements

    May 1, 2018, 00:00
  • Utilization, Spending, and Prices Trends for Anti-Epileptic Drugs (AEDS) in the U.S. Medicaid Programs- Empirical Data Analysis from 2010 to 2016

    May 1, 2018, 00:00
  • Racial Disparity in the Use of First-Line Psychosocial Care For Children and Adolescents Initiating Therapy on Antipsychotics

    May 1, 2018, 00:00
  • Identifying Community-Reported Health Priorities Using Free Listing Interviews in a Mixed Methods Approach

    May 1, 2018, 00:00
  • Primary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines- A Retrospective Cohort Analysis

    May 1, 2018, 00:00
  • Patterns of Treatment and Recurrence In Patients with Non-Metastatic Melanoma WHO Underwent Lymph Node Dissection Surgery

    May 1, 2018, 00:00
  • Simultaneous Development of Patient-Reported Outcome Measures for Masseter Muscle Hypertrophy in An Asia Population

    May 1, 2018, 00:00
  • Time for Reimbursement for Orphan Drugs in EU5

    May 1, 2018, 00:00
  • Pneumococcal Vaccines Produce Substantial Cost-Savings in Mexico

    May 1, 2018, 00:00
  • Prevalence of Anxiety Symptoms and its Correlates Among Medical Students in China- A National Survey in 33 Universities

    May 1, 2018, 00:00
  • Long-Term Benefits of Employee Wellness Programs- A Blue Cross Blue Shield of Louisiana (BCBSLA) Case Study

    May 1, 2018, 00:00
  • Real-World Treatment Patterns For Patients With Head And Neck Squamous Cell Carcinoma (HNSCC) Treated With Immuno-Oncology (IO) Therapy

    May 1, 2018, 00:00
  • Adherence Issues in Osteoarthritis- How can Acceptance Measurement Help Understanding Patients' Concerns and Working on Solutions?

    May 1, 2018, 00:00
  • What Is The Future Of Indication-Based Pricing And Contracting (IBPC) For Market Access Of New Oncologic And Biologic Agents In Major Global Markets?

    May 1, 2018, 00:00
  • Price Analysis of Immunosuppressants Which are Approved By FDA as Anti-Rejection Therapy for Kidney Transplantation in the United States

    May 1, 2018, 00:00
  • Converting Eortc QLQ-C30 Scores To EQ-5D Utility Scores in the Brigatinib Alta Study

    May 1, 2018, 00:00
  • Cost-Effectiveness of a Fixed-Dose Combination Therapy of Lesinurad and Allopurinol for Second-Line Gout Therapy- A US Payer Perspective

    May 1, 2018, 00:00
  • Ventilator-Associated Pneumonia- Validity of Quality Metrics and Outcomes of Current Practices

    May 1, 2018, 00:00
  • The Cost-Effectiveness Analysis of Rhtpo Versus Il-11 on The Treatment of Chemotherapy-Induced Thrombocytopenia Patients in China

    May 1, 2018, 00:00
  • Hypoactive Sexual Desire Disorder (HSDD) is not “The Female Erectile Dysfunction (ED)”- Challenges with the Characterization of HSDD in Women

    May 1, 2018, 00:00
  • Low Birth Weight in Newborns and Associated Maternal and Neonatal Factors in a Colombian Gineco-Obstetrical Hospital

    May 1, 2018, 00:00
  • Cost-Benefitanalysis of Hepatitis B Vaccination Strategies for Preventing Mother-to-Child Transmission:A Decision Tree-Markov Model

    May 1, 2018, 00:00
  • Commercialising Regenerative Medicines in the US – What Lessons can We Learn from Europe?

    May 1, 2018, 00:00
  • A Predictive Modeling Approach that Accurately Identifies Members with the Likelihood of Having a Future Costly Event

    May 1, 2018, 00:00
  • Cost - Effectiveness Analysis of Ultrasound Screening for Thyroid Cancer in Asymptomatic Population

    May 1, 2018, 00:00
  • Readiness of Community Oncology and Urology Practices for Value-Based Care

    May 1, 2018, 00:00
  • Validation of a Claims-Based Algorithm for Identification of Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) in the US

    May 1, 2018, 00:00
  • A Review of Definition of Smoking Status When Using Electronic Medical/Health Records and Claims Databases In Studies

    May 1, 2018, 00:00
  • New Estimates of the Willingness-to-Pay for a Statistical Life Year- A Systematic Review of the Empirical Economic Literature

    May 1, 2018, 00:00
  • Drug Utilization Review of Acute Coronary Syndrome Patients in Hong Kong and United States

    May 1, 2018, 00:00
  • The Total Direct Healthcare Expenditures of Diagnosed Drug Dependen Evidence from United States National Survey Data

    May 1, 2018, 00:00
  • Deficit of the Hungarian Health Insurance Fund Between 1994-2014

    May 1, 2018, 00:00
  • Patient and Provider Characteristics Associated with PHQ-9 Administration and Outcomes Assessment in Routine Clinical Practi Findings from the OM1 Data Cloud

    May 1, 2018, 00:00
  • The Economic Burden of Varicella in Mexico

    May 1, 2018, 00:00
  • An Exact Method For Estimating Standard Errors From Zero-Inflated Gamma Distributions For Healthcare Cost Data

    May 1, 2018, 00:00
  • Efficacy of Brodalumab in the Treatment of Moderate-To-Severe Psoriasis- A Network Meta-Analysis

    May 1, 2018, 00:00
  • The Role of General Practitioners During Economic Crises

    May 1, 2018, 00:00
  • Healthcare Resource Utilization and Costs Among Commercially Insured Patients with Juvenile Idiopathic Arthritis (JIA) in the United States

    May 1, 2018, 00:00
  • Perceptions of Cost Pressure Associated with Biosimilars Among Physicians in Europe

    May 1, 2018, 00:00
  • A Review of Patient-Reported Outcomes in Nonalcoholic Steatohepatitis (NASH)

    May 1, 2018, 00:00
  • Developing Content for a New Generic Qaly Measure- Results from a Qualitative Literature Review (E-Qaly Project)

    May 1, 2018, 00:00
  • Cost - Effectiveness of the use of the Insulin Pump Therapy Versus Daily Multiple Injections in Patients with Type 1 Diabetes at the Mexican Institute of Social Security

    May 1, 2018, 00:00
  • Adherence and Persistence with Antiplatelet Agents in Patients with New Episode of Acute Coronary Syndrome in Tianjin, China

    May 1, 2018, 00:00
  • Interseizure Interval In Frequently Admitted Epilepsy Patients

    May 1, 2018, 00:00
  • Use of Anti-Diabetic Medication is Not Associated with Cancer Risk in Chinese Patients with Type 2 Diabetes

    May 1, 2018, 00:00
  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Hereditary Angioedema- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00
  • Opioid Use Among Patients Presenting with Migraine in the Emergency Department

    May 1, 2018, 00:00
  • Testosterone Replacement Therapy Reduces Cardiovascular Events in Men with Chronic Kidney Disease

    May 1, 2018, 00:00
  • Small Changes, Big Differences? Cohort Variation by Parameter Specifications in Claims-Based Drug use Evaluations

    May 1, 2018, 00:00
  • Economic Impact of Treatment Adherence in Exocrine Pancreatic Insufficiency (EPI) Patients Treated with Pancreatic Enzyme Replacement Therapy (PERT)

    May 1, 2018, 00:00
  • Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung Cancer (NSCLC) in the United States

    May 1, 2018, 00:00
  • Effectiveness of the Treatment with New Antivirals in Adult Patients with Chronic Infection with Hepatitis C Virus in Colombia During 2016-2017

    May 1, 2018, 00:00
  • Anti-Vegf Dosing Intervals in Patients with Neovascular Age-Related Macular Degeneration- a Retrospective Cohort Study in Australia

    May 1, 2018, 00:00
  • Identifying Priority Regions for Improving Treatment Options for Illicit Drug Dependence

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Nilotinib Versus High-Dose Imatinib for the Second-Line Treatment of Chronic Myeloid Leukemia In China - Based on Nation-Wide Data

    May 1, 2018, 00:00
  • Copyright/Subscription

    May 1, 2018, 00:00
  • Efficacy and Safety of Vedolizumab in the Treatment of Ulcerative Colitis- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00
  • A Systematic Review and Network Meta-Analysis of Panitumumab with Chemotherapy in the First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer (MCRC) with Left-Sided Tumors

    May 1, 2018, 00:00
  • Parent and Adult Patient Attitudes About Gene Therapy as a Therapeutic Option for Duchenne Muscular Dystrophy

    May 1, 2018, 00:00
  • Extended Thromboprophylaxis With Betrixaban Is Cost-Effective In Acutely ILL Medical Patients

    May 1, 2018, 00:00
  • Resource Use Related to Pediatric Lower Limb Spasticity in Canada- Physician Questionnaire

    May 1, 2018, 00:00
  • Characteristics and Rate of Subsequent Lumbar Spine Fusion Surgery Among Patients Treated with Allogenic Cellular Bone Matrix for Posterior Lumbar Spinal Fusion

    May 1, 2018, 00:00
  • Demographic Variation of Hepatitis C Virus (HCV) Prevalence in the US- Results from the National Health and Nutrition Examination Survey 2009 – 2016

    May 1, 2018, 00:00
  • Budget Impact Analysis For Olaparib Maintenance Therapy for Brca-Mutated Platinum Sensitive Recurrent Ovarian Cancer in Costa Rica

    May 1, 2018, 00:00
  • Effect of Patient Involvement in Treatment Decision Making on Disease Outcomes in Rheumatoid Arthritis in the EU5

    May 1, 2018, 00:00
  • A Value Of Information (VOI) Analysis Of Evolocumab For The Prevention Of Cardiovascular Deaths And Incidences In Secondary Prevention Patients

    May 1, 2018, 00:00
  • Adherence and Persistence in Medication Assisted Treatment Among Pregnant Women with Opioid use Disorder

    May 1, 2018, 00:00
  • Complications Related Health Utility Decrements for Type 2 Diabetes Population in the United States

    May 1, 2018, 00:00
  • Creating a Flexible Continuous Procedure Distribution Model Based on Pre-Test Risk Level for Lung Cancer in Patients with Incidentally Detected Pulmonary Nodules

    May 1, 2018, 00:00
  • Comparative Effectiveness Analysis Using Real World Evidence (RWE) and Applying a Causal Marginal Structural Model- the Case of Second-Line Treatment in Patients with Ovarian Cancer

    May 1, 2018, 00:00
  • Cost-Effectiveness of Abaloparatide for the Treatment of Postmenopausal Women with Osteoporosis

    May 1, 2018, 00:00
  • Treatment Practice Patterns, Healthcare Resource Utilization (HRU), and Costs in Newly Diagnosed Patients with Therapy-Related Acute Myeloid Leukemia (TAML) or AML with Myelodysplasia-Related Changes (AML-MRC) in a United States (US) Commer ...

    May 1, 2018, 00:00
  • Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV)

    May 1, 2018, 00:00
  • Adherence Issues in COPD- How Can Acceptance Measurement Help Understanding Patients' Concerns and Working on Solutions?

    May 1, 2018, 00:00
  • The Burden of Sickle Cell Disease

    May 1, 2018, 00:00
  • Does Exposure to Health Valuation Tasks Impact One’s Self Rated Health?

    May 1, 2018, 00:00
  • Estimation of Total Burden of Bladder Cancer in Brazil – An Economic and Clinical Approach

    May 1, 2018, 00:00
  • Changes in Healthcare Resource use and Costs Associated with the use of Adjunctive Atypical Antipsychotics In Major Depressive Disorder

    May 1, 2018, 00:00
  • Analyzing Prescription Data to Target Hard-To-Identify Patient Populations for Clinical Trials- A Case Study in Narcolepsy

    May 1, 2018, 00:00
  • The Economic Impact of Shingles Vaccine Disparities Among Hispanics

    May 1, 2018, 00:00
  • Measurement Equivalence of Patient-Reported Outcome Measure Response Scale Types Collected Using Bring Your Own Device Compared to Paper and a Provisioned Device- Results of a Randomized Equivalence Trial

    May 1, 2018, 00:00
  • Factors Associated with Data Collection Duration and Participation Rates in Retrospective Noninterventional Medical Record Review Studies

    May 1, 2018, 00:00
  • Persistence and Adherence at 12 Months with Subcutaneously Administered Biologics Among Biologic-Naive and -Experienced Patients With Psoriatic Arthritis- Analyses From A Us Claims Database

    May 1, 2018, 00:00
  • Budget Impact Analysis of two Approved Therapies for Idiopathic Pulmonary Fibrosis

    May 1, 2018, 00:00
  • Evaluation of Modified Item Characteristics on Item Comprehension and Psychometric Performance

    May 1, 2018, 00:00
  • Medication Usage, Length of Stay, and Hospital Charges in Bipolar Disorder Patients- A Retrospective Analysis of a Large Us Electronic Health Record Database

    May 1, 2018, 00:00
  • Payer Perspectives on Gene Therapy Reimbursement in the United States

    May 1, 2018, 00:00
  • Total Costs Distribution for Multiple Myeloma in Single Upper Middle Income Country- Is Cost Data Distribution Comparable with High Income Countries?

    May 1, 2018, 00:00
  • Early Check- A Voluntary Newborn Screening Program and Research Registry to Facilitate Clinical Trials in Pre-Symptomatic Infants with Rare Diseases

    May 1, 2018, 00:00
  • Reviewing Adverse Drug Event Reporting Between Randomized Clinical Trial Data and Real World Post Market Data for Sorafenib and Sunitinib

    May 1, 2018, 00:00
  • Incremental Burden of Diabetes Complications on Quality of Life and Healthcare Expenditures in the United States

    May 1, 2018, 00:00
  • Comparing the Costs and Outcomes of a Twin Interlocking Derotation and Compression Screw Cephalomedullary Nail (2-Screw Nail)* with a Single Screw Cephalomedullary Nail (Single-Screw Nail) in Patients with Intertrochanteric HIP Fractures

    May 1, 2018, 00:00
  • Inpatient Admission Length Of Stay And Costs Among Vascular Procedure Patients Receiving Perclose Proglide Suture-Mediated Closure Compared To Patients Receiving Surgical Cutdown For Closure Of Large Bore Arterial Access

    May 1, 2018, 00:00
  • Comparison of Healthcare Resource Utilization and Clinical Status Among Type 2 Diabetes Patients Using Multiple-Daily Injection (MDI) Insulin Therapy Versus Non-Mdi Therapy

    May 1, 2018, 00:00
  • Healthcare Resource Utilization Among Patients with Angelman Syndrome Stratified By Age

    May 1, 2018, 00:00
  • Disease Burden and Integreted Disease Management of Biologic Treated Psoriasis Patients with Psoriatic Arthritis in Clinical Practi Results from Multicountry Study in EU5

    May 1, 2018, 00:00
  • Statins Adherence And Its Risk Factors Analysis in Chinese Ascvd Patients Based on A Provincial Claim Data

    May 1, 2018, 00:00
  • Budget Impact Analysis of Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel in the Mexican Public Healthcare System

    May 1, 2018, 00:00
  • Cost-Effectiveness Evaluation of Enzalutamide and Abiraterone for the Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel in the Mexican Public Healthcare System

    May 1, 2018, 00:00
  • Unmet Needs in the Management of Hypoactive Sexual Desire Disorder in Premenopausal Women

    May 1, 2018, 00:00
  • Real World Practice and Patient-Reported Outcomes of Uncontrolled Hypertensive Patients In Korea

    May 1, 2018, 00:00
  • Effect of Cash Prescriptions on Statin, Antihypertensive, And Antidiabetic Medication Adherence Estimates in the Commercially-Insured Population

    May 1, 2018, 00:00
  • The Costs of Intensifying Type 2 Diabetes Patients Treated with Basal Insulin to Basal in Combination with GLP-1- A Physician Survey

    May 1, 2018, 00:00
  • Do Medical Homes Affect Healthcare Utilization Rates? A Longitudinal Evaluation on Medical Home Implementation in Italy

    May 1, 2018, 00:00
  • Reimbursement Decision-Making in Ukraine- Current and Future Directions

    May 1, 2018, 00:00
  • Global Burden of Seasonal Influenza Disease- A Structured Literature Review

    May 1, 2018, 00:00
  • Estimated Budget Impact Of Cholesterol Decreasing In The Russian Population

    May 1, 2018, 00:00
  • Cost Effectiveness Of Direct Oral Anticoagulants (DOACS) Compared With Warfarin- A Literature Review

    May 1, 2018, 00:00
  • Challenges in Outlier Surgeon Assessment in the Era of Public Reporting

    May 1, 2018, 00:00
  • Prevalence, Disease Burden and Unmet Needs of Patients With Essential Tremor- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00
  • Cost-Effectiveness of Empagliflozin in Chinese Patients with Type 2 Diabetes and Established Cardiovascular Disease- A Discrete Event Simulation Economic Modelling Study

    May 1, 2018, 00:00
  • Real World Incidence and Prevalence of Systematic Lupus Erythematosus in Alberta, Canada

    May 1, 2018, 00:00
  • Association of Treatment Resistant Depression with Healthcare Resource Utilization and Physician Satisfaction with Disease Management

    May 1, 2018, 00:00
  • Modeling the Public Health Impact of Varicella Vaccination in Argentina- Implications of Vaccine Choice and Dosing Schedules

    May 1, 2018, 00:00
  • Quality of Life of Adults with a History of Juvenile Idiopathic Arthritis- A Systematic Review

    May 1, 2018, 00:00
  • Economic Burden of Infant-Onset (Type 1) Spinal Muscular Atrophy- A Retrospective Claims Database Analysis

    May 1, 2018, 00:00
  • Comparing Cost-Per-Qalys Gained And Cost-Per-Dalys Averted Analyses

    May 1, 2018, 00:00
  • Cost-Effectiveness Evaluation of Ertapenem in the Treatment of Adult Patients with Community-Acquired Complicated Intraabdominal Infection

    May 1, 2018, 00:00
  • The Direct Cost Burden of Tuberous Sclerosis Complex Among Insured Patients in the US

    May 1, 2018, 00:00
  • Psychometric Validation of the 1-Month Recall Uterine Fibroid Symptom and Health-Related Quality-of-Life Questionnaire

    May 1, 2018, 00:00
  • Non-Adherence to Antipsychotics and Disease Comorbidity- A Double Whammy in Schizophrenia Management

    May 1, 2018, 00:00
  • Chi-Square Automatic Interaction Detection (CHAID) Analysis- Understanding and Informing Treatment Choice of Second-Line Metastatic Urothelial Cancer Therapy

    May 1, 2018, 00:00
  • An Evaluation of the Cost-Effectiveness of Reslizumab in Poorly Controlled Eosinophilic Asthma

    May 1, 2018, 00:00
  • Cost-Utility Analysis of Injectable Paliperidone Palmitate 3-Month Formulation Versus Injectable Risperidone and Oral Antipsychotics For The Treatment Of Schizophrenia In Colombia

    May 1, 2018, 00:00
  • Valuing Health-Related Quality of Life for Inpatients with Diabetes-Related Complications In China

    May 1, 2018, 00:00
  • Demonstration of Ngram Frequency and Cluster Method for Identifying Signals of Transfusion Reactions (TR)

    May 1, 2018, 00:00
  • Hospitalization Outcomes For Adults In The United States With Atrial Septal Defect- Analysis Of A Multicenter Database

    May 1, 2018, 00:00
  • Characterizing the Clinical and Economic Burden of Type 2 Diabetes (T2DM) Patients on Multiple Daily Injections (MDI) of Insulin- A Systematic Literature Review

    May 1, 2018, 00:00
  • Real World Experience with Calcipotriene and Betamethasone Dipropionate Foam 0.005%/0.064% (Cal/BD Foam) in the Treatment of Adult Psoriasis Including Psoriasis Itch from Retrospective Chart Review

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Bronchial Thermoplasty Versus Pharmacological Therapies in Patients with Severe Asthma in Mexico, Colombia and Spain

    May 1, 2018, 00:00
  • Health Care Utilization and Economic Burden of Patients With Inflammatory Bowel Disease in the US Department of Defense Population

    May 1, 2018, 00:00
  • Evaluation of Cost of Hospitalizations Related to Nausea and Vomiting Among Cancer Patients

    May 1, 2018, 00:00
  • Serum Autoantibodies Multi-Testing in Rheumatoid Arthritis in Primary Care can Reduce Avoidable Costs Associated to False Positives. A Simulation Study in the United States of America

    May 1, 2018, 00:00
  • Impact of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Utilization and Healthcare Costs Among Individuals with Type 2 Diabetes Mellitus

    May 1, 2018, 00:00
  • The Association Between Adherence with Statin Therapy and Risk of Dementia Among Diabetic Patients with Comorbid Hyperlipidemia

    May 1, 2018, 00:00
  • Policies and Processes Applicable to Drugs for Very Rare Diseases in Australia, Canada, England, France and Germany

    May 1, 2018, 00:00
  • New Drugs Approval in Italy- Updated Analysis of the Applied Negotiation Conditions 2015-2017

    May 1, 2018, 00:00
  • Economic Impact of Dengue in Brazil Over 10 Years (2008-2017)

    May 1, 2018, 00:00
  • The Prevalence and Treatment Patterns of Women of Child Bearing Age (WOCBA) with Psoriasis (PSO)

    May 1, 2018, 00:00
  • Methods for Reporting the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Data in Cancer Clinical Trials

    May 1, 2018, 00:00
  • Humanistic And Economic Burden Associated With Anxiety And Depression Among Adults With Diabetes And Hypertension

    May 1, 2018, 00:00
  • Trends in Baseline Retinal Examinations and Associated Factors Among New Initiators of Hydroxychloroquine in Medicare- 2011-2015

    May 1, 2018, 00:00
  • A Review of Health Technology Assessments (HTA) of PCSK9 Inhibitors (PSCK9I)

    May 1, 2018, 00:00
  • A Review of the International New Drug Landscape

    May 1, 2018, 00:00
  • Access to Patient-Centered Medical Home Care Among Adults with Chronic Conditions- Findings from the Medical Expenditures Panel Survey

    May 1, 2018, 00:00
  • Predictors and Incidence of Cardiovascular Events in Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00
  • Lifetime Cost-Effectiveness of Adjuvant External Beam Whole Breast Irradiation (EBWBI) in Estrogen Receptor Positive (ER+) Early-Stage Breast Cancer (ESBC) Women- Cardiotoxicity Consideration

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Regorafenib in Patients with Advanced Hepatocellular Carcinoma

    May 1, 2018, 00:00
  • Is Self-Rated Health of Americans Different in 2017 Compared to 2002?

    May 1, 2018, 00:00
  • Systematic Literature Review of Treatments for Patients with Untreated Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    May 1, 2018, 00:00
  • How Health Technology Assessment Programs Take Into Account the Patient Perspective in Healthcare Decision Making- Comparison Between the United States and Several European Countries

    May 1, 2018, 00:00
  • Alirocumab Possession Among Medicare Advantage Patients

    May 1, 2018, 00:00
  • Resource use of Patients Diagnosed with Schizophrenia- Analysis of Physician Record form Data in the United States

    May 1, 2018, 00:00
  • Health Behaviors Among Stroke Survivors In The United States- A Propensity Score Matched Study

    May 1, 2018, 00:00
  • Hospital Related Clinical and Economical Outcomes of a Bicruciate Knee System in Total Knee Arthroplasty Patients

    May 1, 2018, 00:00
  • Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Prostate Cancer Patients With or without Metastasis

    May 1, 2018, 00:00
  • Budget Impact for Olaparib Maintenance Therapy for Brca-Mutated Platinum Sensitive Recurrent Ovarian Cancer in Peru

    May 1, 2018, 00:00
  • Economic Burden Of Renal Cell Carcinoma Among Older Adults In The Targeted Therapy ERA

    May 1, 2018, 00:00
  • Impact Of Dining Out And Food Intake Pattern On Atrial Fibrillation Prevalence In Hong Kong Chinese Elders

    May 1, 2018, 00:00
  • Using Machine Learning to Predict Opioid Overdoses Among Prescription Opioid Users

    May 1, 2018, 00:00
  • Medical Expenditures for Patients with Pulmonary Embolism Among the Population with Urban Basic Health Insurance in China

    May 1, 2018, 00:00
  • Selecting Health States for EQ-5D-3L Valuation Studies- Statistical Considerations Matter

    Apr 1, 2018, 00:00
  • Table of Contents

    Apr 1, 2018, 00:00
  • A Framework for Measuring Low-Value Care

    Apr 1, 2018, 00:00
  • Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom

    Apr 1, 2018, 00:00
  • Sustained 3-Year Benefits in Quality of Life After Percutaneous Coronary Interventions in the Elderly- A Prospective Cohort Study

    Apr 1, 2018, 00:00
  • Editorial Board

    Apr 1, 2018, 00:00
  • Utility-Based Instruments for People with Dementia- A Systematic Review and Meta-Regression Analysis

    Apr 1, 2018, 00:00
  • Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV- A Systematic Literature Review

    Apr 1, 2018, 00:00
  • The CDI-DaySyms- Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection

    Apr 1, 2018, 00:00
  • Copyright/Subscription

    Apr 1, 2018, 00:00
  • Modeling Clinical Outcomes in Prostate Cancer- Application and Validation of the Discrete Event Simulation Approach

    Apr 1, 2018, 00:00
  • Are US Health Insurers Efficient or Not?

    Apr 1, 2018, 00:00
  • The Use of MCDA in HTA- Great Potential, but More Effort Needed

    Apr 1, 2018, 00:00
  • Assessment of Reliability and Validity of SF-12v2 among a Diabetic Population

    Apr 1, 2018, 00:00
  • «
  • 71
  • 72 (current)
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »